Madrigal Pharmaceuticals, Inc. (MDGL)
476.91
-10.81
(-2.22%)
USD |
NASDAQ |
Oct 08, 16:00
476.71
-0.20
(-0.04%)
Pre-Market: 20:00
Madrigal Pharmaceuticals Total Return Level : 476.91 for Oct. 8, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| October 08, 2026 | 476.91 |
| October 07, 2026 | 487.72 |
| October 06, 2026 | 496.45 |
| October 05, 2026 | 493.62 |
| October 02, 2026 | 499.40 |
| October 01, 2026 | 499.71 |
| September 30, 2026 | 503.96 |
| September 29, 2026 | 509.44 |
| September 28, 2026 | 517.04 |
| September 25, 2026 | 516.56 |
| September 24, 2026 | 513.21 |
| September 23, 2026 | 513.02 |
| September 22, 2026 | 518.83 |
| September 21, 2026 | 521.96 |
| September 18, 2026 | 531.52 |
| September 17, 2026 | 534.40 |
| September 16, 2026 | 529.09 |
| September 15, 2026 | 523.26 |
| September 14, 2026 | 540.06 |
| September 11, 2026 | 534.49 |
| September 10, 2026 | 533.12 |
| September 09, 2026 | 546.66 |
| September 08, 2026 | 534.16 |
| September 04, 2026 | 541.08 |
| September 03, 2026 | 542.61 |
| Date | Value |
|---|---|
| September 02, 2026 | 546.93 |
| September 01, 2026 | 538.71 |
| August 31, 2026 | 540.03 |
| August 28, 2026 | 533.76 |
| August 27, 2026 | 543.69 |
| August 26, 2026 | 538.88 |
| August 25, 2026 | 512.16 |
| August 24, 2026 | 511.97 |
| August 21, 2026 | 516.74 |
| August 20, 2026 | 519.09 |
| August 19, 2026 | 540.16 |
| August 18, 2026 | 524.37 |
| August 17, 2026 | 524.87 |
| August 14, 2026 | 507.56 |
| August 13, 2026 | 507.37 |
| August 12, 2026 | 536.20 |
| August 11, 2026 | 535.27 |
| August 10, 2026 | 515.34 |
| August 07, 2026 | 510.04 |
| August 06, 2026 | 510.36 |
| August 05, 2026 | 514.12 |
| August 04, 2026 | 507.56 |
| August 03, 2026 | 482.00 |
| July 31, 2026 | 467.32 |
| July 30, 2026 | 493.11 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Alnylam Pharmaceuticals, Inc. | 224.53 |
| Exelixis, Inc. | 59.02 |
| Insmed, Inc. | 100.48 |
| United Therapeutics Corp. | 532.78 |
| Karyopharm Therapeutics, Inc. | 0.60 |